logo
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseases
Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy—results of a randomized trial
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias
Salvage chemotherapy according to the ASHAP protocol
Urinary proteins in multiple myeloma
Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy
Involvement of Fas and TNF pathways in the induction of apoptosis of T cells by antithymocyte globulin
CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease
Terminal differentiation in vitro of patient-derived post-TMD megakaryoblastic AML cells
Inflammatory pseudotumor of the spleen in a patient with human immunodeficiency virus infection
T-cell prolymphocytic leukemia with autoimmune manifestations in Nijmegen breakage syndrome
Testicular plasmacytoma with bone dissemination without medullary plasmacytosis
Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient
Henoch-Schönlein IgA glomerulonephritis complicating myeloma kidneys
Incorrect measurement of leukocyte counts in post-bone marrow transplantation (P-BMT) patients
Fournier's gangrene
Challenges with linezolid therapy and reversible pancytopenia
Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma